Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia

Annals of Saudi Medicine

Volumn 30, Issue 5, 2010, Pages

  Al Johani, Sameera ^a   Akhter, Javed ^a   Balkhy, Hanan ^a   El Saed, Ayman ^a   Younan, Mousaad ^a   Memish, Ziad ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SAUDI ARABIA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; TERTIARY HEALTH CARE; URINALYSIS;

ACINETOBACTER BAUMANNII; ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; GENTAMICINS; GRAM-NEGATIVE BACTERIA; HOSPITALS; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; PREVALENCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; SAUDI ARABIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77956261618     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.67073     Document Type: Article

References (19)

1. Chopra I, Schofield C, Everett M, ONeill A, Miller K, Wilcox M, et al. Treatment of health-care-associated infections caused by gram negative bacteria: A consensus statement. Lancet Infect Dis 2008;8:133-9.
2. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001;29:64-8.
3. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
4. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistance Acinetobacter baumanii. J Antimicrob Chemother 2007;59:772-4.
5. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: A systematic review. J Hosp Infect 2008;70:101-8.
6. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538-82.
7. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial testing. NCCLS, Wayne PAS edition; 2001. Suppl, p. M100-S11.
8. Isenberg HD, editor. Clinical Microbiology Procedures Handbook. Vol. 1-2 American Society of Microbiology; 2007.
9. Floros J, Roussos C. Infection control in the ICU. Respir Ther 2001;32.
10. Shulman L, Ost D. Managing infection in the critical care unit: How can infection control make the ICU safe. Crit Care Clin 2005;21:111-28.
11. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit: A European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004;3:14.
12. Chatterjee I, Iredell JR, Woods M, Lipman J. The implications of enterococci for the intensive care unit. Crit Care Resusc 2007;9:69-75.
13. Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram negative bacilli in Europe. Euro Surveill 2008;13:47.
14. Centers for Disease Control and Prevention/National Nosocomial Infections Surveillance System. Rates of resistance among nosocomial infections reported in 15. Intensive care unit patients: Comparison of Jan-May 1999 with historical data [database online]. Atlanta: Ga; CDC/NNIS. 2000.
15. Eltahawy AT, Khalaf RM. Antibiotic resistance among gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia. J Chemother 2001;13:260-4.
16. Rotimi VO, al-Sweih NA, Feteih J. The prevalence and antibiotic susceptibility pattern of gram negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diagn Microbiol Infect Dis 1998;30:53-9.
17. Qadri SMH, Akhter J, Lee GC. Etiology of ICU infections and antibiogram of the isolates at a referral center in Riyadh. S Pharm J 1996;4:174-7.
18. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIIC) Study. JAMA 1995;274:639-44.
19. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008;52:1430-7.